This initial dose serves primarily as a tolerability step rather than a therapeutic dose, allowing your body to adjust to the medication's effects on glucose regulation and gastric emptying
As described above, GLP-1RAs attenuate albuminuria and marginally reduce eGFR decline
GLP-1R is a G protein-coupled receptor, or GPCR, that has been widely studied because receptor activation connects extracellular peptide signaling with intracellular pathways such as cyclic AMP generation, protein kinase A signaling, receptor internalization, and downstream transcriptional responses
What you do alongside the medication determines both your success during treatment and your outcome if you eventually stop
While most side effects are mild and tend to dissipate with time, GLP-1 medications are associated with additional issues such as gallbladder disease, pancreatic inflammation, and gastroparesis
The program, called Pharmacy Forward, is supported by a $100 million investment through 2028, Cigna said